Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Informal meeting and trials news

    Our next meeting will be an informal one on March 10. All members, spouses, partners welcome. 7pm at BAWA. Free buffet! There is a push to get more men in the South West interested and involved in prostate cancer clinical trials. We are publishing information here to help increase the numbers. There is a list of trials currently open in the Bristol area that you can search on https://www.ukctg.nihr.ac.uk/home/

  • Concert invitation

    Members are invited to a joint concert by Cheddar Male Choir and Taunton Dean Male Voice Choir on March 11 (7.30pm) in Victoria Methodist Church, Weston-super-Mare, in aid of prostate cancer initiatives. Tickets ÂŁ8, pay at the door.

  • News column: Big breakthrough

    The biggest leap in diagnosing prostate cancer “in decades” has been made using new advanced MRI scanning equipment. See. But only a third of men can benefit, says Prostate Cancer UK. See. And a US study of prostate cancer patients found a link between brisk walking and lowered risk of prostate cancer progression. See 

  • Defeating therapy resistance

    A new US study sheds light on a signalling circuit in cells that drives therapy resistance in prostate cancer. Targeting the components of this circuit suppresses advanced cancer development. See

  • Laser treatment a success

    Surgeons described a new treatment for early stage prostate cancer as “truly transformative”. The approach, tested in Europe, uses lasers and a drug made from deep-sea bacteria to eliminate tumours, but without causing severe side effects. See

  • Surprise testosterone finding

    Drastically altering the levels of testosterone could cause cancer cells to die even after they become hormone-resistant, according to new research unveiled in December. See

  • Treatment breakthrough

    After a bombardment of evidence from Prostate Cancer UK, NICE announced in November they will undertake an exceptional review of prostate cancer clinical guidelines. It will mean lifesaving new diagnosis and treatment sooner than expected. See

  • World first hailed

    Scientists in Belfast claim a major breakthrough in prostate cancer treatment. It is hoped the new discovery, hailed a world first, could help stop the spread of the disease and prevent relapses. Researchers have found that combining hormone therapy with a new drug, OCT1002, can improve treatment effectiveness. See

  • PSA test row

    In October the Academy of Medical Royal Colleges reported that the use of PSA testing may be unnecessary. But Prostate Cancer UK made clear the test is still the best first step for prostate cancer diagnosis until a more robust one suitable for a screening programme is devised. Several Prospect members wrote to the BBC or their MP about the situation. See. And crowdfunding donations were successfully sought for a new non-invasive and affordable diagnostic test for the early detection of prostate cancer. To find out more, see

  • Drug to tackle cancer spread

    A radioactive drug, which behaves like the substance used to kill Russian ex-spy Alexander Litvinenko, could be used to treat prostate cancer patients. It targets tumours that have spread to the bones and has been approved by NICE. See

  • Early detection claimed

    Scientists at Israel’s Weizmann Institute might have found a prostate cancer cure, at least if it’s caught in its early stage. See. More news on the newsletter page.

Running

A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us:

0800 035 5302

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked

10 prostate cancer myths debunked. See

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March, recognises teams working together to deliver improved patient care and public health. See a video about their work here. The classes are designed for people who have been affected by cancer and whose quality of life can be maintained or improved by taking part in regular, supervised exercise with cancer specialist instructors. Energise is a partnership between Macmillan, North Bristol NHS Trust, Sports Leisure Management Ltd and Bristol City Council. In a Bristol Post article on the Easton scheme participants tell how it helped them improve mood, vitality and well-being, and to overcome cancer-related fatigue. For more information on Energise see our Helpful links page.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties to replace Sandy Tyndale-Biscoe of Cornwall. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. See. In addition, he or she will participate in occasional meetings or teleconferences. If any Prospect member would like to volunteer for this rewarding role, they can email roger.wotton@tackleprostate.org All expenses are reimbursed.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See. And we have more research news here.

Swedish test shows promise

Swedish researchers found that a test which involved genetic and protein biomarkers (the S3M) was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence the S3M risk assessment model can dramatically cut the number of men undergoing unnecessary biopsies, without compromising their safety. But Prostate Cancer UK says it’s going to be important to validate this study in a more diverse population before it can accept that it will work elsewhere. It is funding more research to develop a new UK risk assessment tool. These plans are still going full-steam ahead, and PCa UK expects to have more to say about this in 2017. See.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Treatment help

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Buddies support ends but…

    The Macmillan Skype Buddy service has closed. But you can still get help or advice from Macmillan by calling 0808 808 0000, Monday to Friday, 9am-8pm, or via their website.

  • Buddies offer home support

    This is a Macmillan service for Bristol, North Somerset and South Gloucestershire and offers support for adult cancer patients in people’s homes for up to 12 weeks. Ring 07543 248714 or email bristolbuddies@macmillan.org.uk